The Chemours Company reported $5.80B of revenue over the trailing twelve months, −0.92% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.80B (to Q2 2026). Net income: −$304M, trailing twelve months to Q2 2026. Free cash flow: $218M, trailing twelve months to Q2 2026. Operating margin: −1.6%, trailing twelve months to Q2 2026.

CCThe Chemours Company

Basic Materials

$13.61-19% 1Y

$13.61

$10.3952 weeks$27.84

CC as reported

The Chemours Company reported $5.80B of revenue over the trailing twelve months, −0.92% on the year before. 11 reported series are charted on this page, each one as filed.

$5.80B

Revenue, trailing twelve months · to Q2 2026 · −0.92% against the twelve months before

Net income: −$304M
Net income · −29% year on year · trailing twelve months to Q2 2026
Free cash flow: $218M
Free cash flow · −504% year on year · trailing twelve months to Q2 2026
Operating margin: −1.6%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.80B	−0.92%	Q2 2026
Net income	−$304M	−29%	Q2 2026
EPS	−$2.00	−30%	Q2 2026
Gross margin	15%	n/a	Q2 2026
Operating margin	−1.6%	n/a	Q2 2026
Net margin	−4.9%	n/a	Q2 2026
ROE	37%	n/a	Q2 2026
ROA	−4.9%	n/a	Q2 2026
ROIC	−1.5%	n/a	Q2 2026
Free cash flow	$218M	−504%	Q2 2026
P/E	82.8	n/a	Q1 2025 · 5 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.